← Open Payments lookup

MICHAEL JOSIAH: Open Payments

NPI 1184264517 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,766 in 76 payments from 12 companies in 2025. Trend: 2023 $1,777 · 2024 $2,224 · 2025 $1,766

Food & beverage: $1,766
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$383
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$318
Otsuka America Pharmaceutical, Inc.15$279
Neurocrine BioSciences, Inc.7$189
Vanda Pharmaceuticals Inc.8$160
Lundbeck LLC5$92
ABBVIE INC.3$81
Supernus Pharmaceuticals, Inc.3$80
Alkermes, Inc.4$72
E.R. Squibb & Sons, L.L.C.3$66

Products named: REXULTI, CAPLYTA, AUSTEDO XR, INGREZZA, HETLIOZ, UZEDY, VRAYLAR, Qelbree.

Industry payments across CA — which companies pay providers there.